BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3127777)

  • 21. Human Wnt-13 is developmentally regulated during the differentiation of NTERA-2 pluripotent human embryonal carcinoma cells.
    Wakeman JA; Walsh J; Andrews PW
    Oncogene; 1998 Jul; 17(2):179-86. PubMed ID: 9674702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 9-cis-retinoic acid induces neuronal differentiation of retinoic acid-nonresponsive embryonal carcinoma cells.
    Yokota Y; Ohkubo H
    Exp Cell Res; 1996 Oct; 228(1):1-7. PubMed ID: 8892963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of alpha 6/beta 1 integrin expression during differentiation of F9 murine embryonal carcinoma cells to parietal endoderm.
    Morini M; Piccini D; Barbieri O; Astigiano S
    Exp Cell Res; 1997 May; 232(2):304-12. PubMed ID: 9168806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The adenovirus-5 12S E1a protein, but not the 13S induces expression of the endoA differentiation marker in F9 cells.
    Velcich A; Ziff EB
    Oncogene; 1989 Jun; 4(6):707-13. PubMed ID: 2543941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stable expression of intracellular Notch suppresses v-Src-induced transformation in avian neural cells.
    Mateos S; Amarir S; Laugier D; Marx M; Calothy G
    Oncogene; 2007 May; 26(23):3338-51. PubMed ID: 17146440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a novel type II activin receptor, type IIA-N, induced during the neural differentiation of murine P19 embryonal carcinoma cells.
    Shoji H; Nakamura T; van den Eijnden-van Raaij AJ; Sugino H
    Biochem Biophys Res Commun; 1998 May; 246(2):320-4. PubMed ID: 9610356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression profiling of lineage differentiation in pluripotential human embryonal carcinoma cells.
    Houldsworth J; Heath SC; Bosl GJ; Studer L; Chaganti RS
    Cell Growth Differ; 2002 Jun; 13(6):257-64. PubMed ID: 12114215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ecotropic viral integration site-1 is activated during, and is sufficient for, neuroectodermal P19 cell differentiation.
    Kazama H; Kodera T; Shimizu S; Mizoguchi H; Morishita K
    Cell Growth Differ; 1999 Aug; 10(8):565-73. PubMed ID: 10470856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultraviolet irradiation, although it activates the transcription factor AP-1 in F9 teratocarcinoma stem cells, does not induce the full complement of differentiation-associated genes.
    Auer HP; König H; Litfin M; Stein B; Rahmsdorf HJ
    Exp Cell Res; 1994 Sep; 214(1):131-8. PubMed ID: 7521841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional regulation of the cellular retinoic acid binding protein I gene in F9 teratocarcinoma cells.
    Means AL; Thompson JR; Gudas LJ
    Cell Growth Differ; 2000 Feb; 11(2):71-82. PubMed ID: 10714763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nestin expression during P19 neuron differentiation].
    Bian W; Yang J; Tang K; Jing NH
    Sheng Li Xue Bao; 1999 Jun; 51(3):246-52. PubMed ID: 11498984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of cellular resistance to pp60v-src kinase-induced cell death.
    Wu LW; Hackett PB
    Oncogene; 1995 Oct; 11(8):1459-68. PubMed ID: 7478570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of human embryonal carcinoma stem cells by immunomagnetic sorting.
    Przyborski SA
    Stem Cells; 2001; 19(6):500-4. PubMed ID: 11713341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The sub-cellular distribution of beta-catenin in the neural differentiation of RA induced P19 EC cells].
    Yang J; Hou HY; Bian W; Lin QS; Jing NH
    Sheng Li Xue Bao; 1998 Dec; 50(6):671-8. PubMed ID: 11367680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Thy-1 glycoprotein is expressed in mouse embryonal carcinoma cells P19.
    Dráber P; Malý P; Hausner P; Pokorná Z
    Int J Dev Biol; 1989 Sep; 33(3):369-78. PubMed ID: 2484657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigations of the expression of the cellular src gene product.
    Brugge JS; Yonemoto W; Lustig A; Golden A
    Princess Takamatsu Symp; 1986; 17():241-9. PubMed ID: 3138228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis.
    Lin X; Gelman IH
    Cancer Res; 1997 Jun; 57(11):2304-12. PubMed ID: 9187136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7).
    Andrews PW; Damjanov I; Berends J; Kumpf S; Zappavigna V; Mavilio F; Sampath K
    Lab Invest; 1994 Aug; 71(2):243-51. PubMed ID: 7521445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The function of inducible promoter systems in F9 embryonal carcinoma cells.
    Miller K; Rizzino A
    Exp Cell Res; 1995 May; 218(1):144-50. PubMed ID: 7737354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenylyl cyclase activity and gene expression during mesodermal differentiation of the P19 embryonal carcinoma cells.
    Lipskaia L; Grépin C; Defer N; Hanoune J
    J Cell Physiol; 1998 Jul; 176(1):50-6. PubMed ID: 9618144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.